PINK — Pilulka Lekarny as Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual income statement for Pilulka Lekarny as, fiscal year end - December 31st, CZK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,780	2,380	2,447	2,132	1,304
Cost of Revenue
Gross Profit	198	238	260	166	112
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,779	2,394	2,495	2,280	1,405
Operating Profit	1.06	-14	-47.7	-148	-101
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-25.1	-24.7	-64	-176	-126
Provision for Income Taxes
Net Income After Taxes	-25.6	-25.7	-65.8	-176	-126
Minority Interest
Net Income Before Extraordinary Items
Net Income	-21.9	-25.5	-64.9	-175	-126
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-21.9	-25.5	-64.9	-175	-126
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-7.81	-5.34	-24.8	-63.7	-44.3
Dividends per Share